FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21303011000001109: Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71060301000001114 Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92726001000001117 Tyverb 250mg tablets (Novartis Pharmaceuticals UK Ltd) 105 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Is a Lapatinib 250mg tablets 105 tablet true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has AMP Tyverb 250mg tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has specific active ingredient Lapatinib ditosylate monohydrate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has specific active ingredient Lapatinib ditosylate monohydrate true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lapatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start